Close Menu

NEW YORK – Diagnostic firm Meridian Bioscience is taking the step forward from just making consumables for other firms developing tests for detecting SARS-CoV-2 to developing its first test for the coronavirus.

It is also partnering to distribute a test developed by another firm.

During the past eight months or so of the COVID-19 pandemic Meridian's involvement in that space has largely been manufacturing reagents and consumables for other firms' SARS-CoV-2 tests, including qPCR chemistries and enzyme master mixes.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.